The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer

Clinical trial NCT00065325 · COMPLETED

Trial details

NCT number: NCT00065325
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Breast Cancer Metastatic Breast Cancer

Start date: 2003-08-01
Primary completion: 2006-06-01
Enrollment: 694

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.